Skip to main content

A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age

Completed · Phase 3 · NCT05436834

Conditions: SARS-CoV-2

At a glance

Research payments reported, 2025
$488,774
U.S. investigators named
30
Sites paid
25
Planned or actual enrollment
1,807

About the trial

Sponsor
ModernaTX, Inc.
Tested
mRNA-1273.214 (biological), mRNA-1273.815 (biological)
Dates
Started 2022-06-21; completion 2025-10-20
Results posted
Not yet

This study will evaluate the safety and immunogenicity of the mRNA-1273.214 vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concerns (VOCs) in participants aged 6 months to \<6 years, when administered as a primary series in SARS-CoV-2 vaccine-naïve participants (Part 1) and a single booster dose (BD) given to participants who previously received 2 doses of the mRNA-1273 vaccine as a primary series (Part 2); and will evaluate the safety and immunogenicity of the mRNA-1273.815 vaccine, when administered as a BD in participants aged 6 months to \<6 years (Part 3) and when administered to SARS-CoV-2 vaccine-naïve participants aged 2 years to \<5 years of a…

From ClinicalTrials.gov, last updated 2025-11-26. Full record, eligibility and contacts (opens in a new tab)

Industry funding

ModernaTX, Inc. reported $488,774 in research payments for this study in 2025 (103 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Coastal Pediatric Research $107,449
  • Dynamed Clinical Research LP $56,893
  • Velocity Clinical Research Inc $46,317
  • Ann & Robert H Lurie Childrens Hospital of Chicago, IL $34,829
  • Elias Research Associates LLC $33,001
  • University of Kentucky Research Foundation $30,396
  • Quality Clinical Research Inc $25,548
  • University of Missouri Health Care, MO $25,536
  • Kur Research LLC $23,988
  • Texas Center for Drug Development $21,838
  • Rex Clinical Trials LLC $14,934
  • Dm Clinical Research - Bellaire $11,863
  • Clinical Research PArtners $8,927
  • Clinical Research Institute Inc $7,719
  • The University of South Florida $7,456
  • Iresearch Atlanta LLC $7,050
  • Meridian Clinical Research LLC $7,036
  • Marwah Investments Corporation $6,070
  • Caribbean Medical Research Center $3,500
  • Med Care Research Corp $2,608
  • Be Well Clinical Studies LLC $2,000
  • Lynn Health Science Institute $1,462
  • Medical University of South Carolina $1,100
  • Seracollection Research Services LLC $1,000
  • Coastal Pediatric Research. $257

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.